Associate Director for Clinical Research at University of New Mexico Cancer Center, The Victor and Ruby Hansen Surface Endowed Chair in Clinical Research (NM,USA)
Dr Edelman is Professor of Hematology/Oncology, The Victor and Ruby Hansen Surface Endowed Chair in Clinical Research and Associate Director for Clinical Research at University of New Mexico Cancer Center (NM, USA).
After leaving active military service, Dr. Edelman joined the faculty at the University of California, Davis and the VA Northern California Health Care System in 1990. He later became Chief of the Division of Hematology and Oncology at the VA. He was a member of the VA National Technical Advisory Group for Oncology and chaired the VA National Oncology Conference for four years. While at UC Davis he was co-director of the thoracic oncology program and developed several trials in lung cancer. In addition, he also initiated trials in GU malignancies, developmental therapeutics and supportive care.
Dr. Edelman was a member of the Lung Cancer and GU committees of the Southwest Oncology Group (SWOG) and chaired two SWOG Phase II trials in lung cancer, both based upon pilot studies performed at UC Davis. In 1999, Dr. Edelman moved to the University of Maryland Greenebaum Cancer Center in Baltimore. He is the Director for Solid Tumor Oncology and clinical leader of the Experimental Therapeutics Program as well as the institutional Principal Investigator for the Cancer and Leukemia Group B (CALGB) at Maryland.
He is a member of the Respiratory Core Committee of the Alliance ( CALGB) and is medical oncology co-chair for the Lung Cancer Steering Committee for RTOG. Currently he leads trials in lung cancer in the Alliance (CALGB) and RTOG as well as a number of clinical and laboratory studies investigating new agents in cancer at the University of Maryland. Dr. Edelman has served as a member of the NIH subcommittee H, the ASCO program committee and several NIH study sections.
In addition, he is Associate Editor of the journal Lung Cancer. This summer he will be moving the University of New Mexico Cancer Center to become Associate Director for Clinical Research.